We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.62B
AUM Growth
+$368M
Cap. Flow
+$229M
Cap. Flow %
8.75%
Top 10 Hldgs %
18.1%
Holding
2,638
New
585
Increased
1,008
Reduced
426
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 4.98%
3 Healthcare 4.3%
4 Consumer Discretionary 3.17%
5 Industrials 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXC icon
1576
DXC Technology
DXC
$1.73B
$19.1K ﹤0.01%
923
+68
+8% +$1.35K
NTSX icon
1577
WisdomTree US Efficient Core Fund
NTSX
$1.4B
$19.1K ﹤0.01%
407
+1
+0.2% +$45
MVF
1578
DELISTED
BlackRock MuniVest Fund
MVF
$19.1K ﹤0.01%
2,513
HXL icon
1579
Hexcel
HXL
$7.82B
$19K ﹤0.01%
308
+190
+161% +$11.9K
CARE icon
1580
Carter Bankshares
CARE
$731M
$19K ﹤0.01%
1,091
BIIB icon
1581
Biogen
BIIB
$30.7B
$18.8K ﹤0.01%
97
-137
-59% -$28.7K
ZETA icon
1582
Zeta Global
ZETA
$6.69B
$18.8K ﹤0.01%
+630
New +$14.8K
TYL icon
1583
Tyler Technologies
TYL
$12.8B
$18.7K ﹤0.01%
+32
New +$18K
SPSC icon
1584
SPS Commerce
SPSC
$2.64B
$18.6K ﹤0.01%
+96
New +$18.8K
NMFC icon
1585
New Mountain Finance
NMFC
$732M
$18.6K ﹤0.01%
1,553
AI icon
1586
C3.ai
AI
$1.59B
$18.6K ﹤0.01%
767
-125
-14% -$3.18K
PCH
1587
DELISTED
PotlatchDeltic
PCH
$18.6K ﹤0.01%
412
+24
+6% +$1.02K
HQY icon
1588
HealthEquity
HQY
$8.75B
$18.5K ﹤0.01%
226
+146
+183% +$11.3K
NEAR icon
1589
iShares Short Maturity Bond ETF
NEAR
$4.85B
$18.4K ﹤0.01%
359
DFP
1590
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$427M
$18.4K ﹤0.01%
855
CHRD icon
1591
Chord Energy
CHRD
$7.39B
$18.2K ﹤0.01%
140
+49
+54% +$7.52K
CMA
1592
DELISTED
Comerica
CMA
$18.2K ﹤0.01%
304
+4
+1% +$221
TRMB icon
1593
Trimble
TRMB
$13.9B
$18.2K ﹤0.01%
293
-57
-16% -$3.18K
SZNE
1594
DELISTED
Pacer CFRA-Stoval Equal Weight Seasonal Rotation ETF
SZNE
$18.2K ﹤0.01%
465
+376
+422% +$14.3K
UPST icon
1595
Upstart Holdings
UPST
$3.03B
$18.1K ﹤0.01%
452
FDD icon
1596
First Trust STOXX European Select Dividend Income Fund
FDD
$908M
$18.1K ﹤0.01%
1,450
ROK icon
1597
Rockwell Automation
ROK
$49B
$18K ﹤0.01%
67
+42
+168% +$11.2K
DYNF icon
1598
BlackRock US Equity Factor Rotation ETF
DYNF
$40B
$18K ﹤0.01%
+363
New +$17.3K
LRN icon
1599
Stride
LRN
$3.43B
$17.8K ﹤0.01%
+209
New +$16.2K
VLUE icon
1600
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
$17.8K ﹤0.01%
163

Similar funds

Geneos Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geneos Wealth Management held 2,638 positions worth $2.62B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Geneos Wealth Management deployed $229M of net new capital in Q3 2024, opening 585 new positions and adding to 1,008 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.
  • Geneos Wealth Management added most to PGIM Ultra Short Bond ETF in Q3 2024, an estimated $9.4M increase.
  • Geneos Wealth Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited iShares MSCI Germany ETF in Q3 2024, selling an estimated $2.37M.
  • Geneos Wealth Management's ten largest holdings make up 18% of its $2.62B portfolio in Q3 2024.
  • Geneos Wealth Management opened 585 new positions and closed 81 in Q3 2024.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $2.62B.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.